venBio Select Advisor as of Sept. 30, 2017
Portfolio Holdings for venBio Select Advisor
venBio Select Advisor holds 40 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Immunomedics | 16.3 | $218M | 16M | 13.98 | |
| Amicus Therapeutics (FOLD) | 10.7 | $142M | 9.4M | 15.08 | |
| Kite Pharma | 6.7 | $89M | 497k | 179.81 | |
| Array BioPharma | 5.4 | $72M | 5.9M | 12.30 | |
| Clovis Oncology | 4.8 | $65M | 786k | 82.40 | |
| Medicines Company | 4.8 | $64M | 1.7M | 37.04 | |
| Ascendis Pharma A S (ASND) | 4.4 | $59M | 1.6M | 36.25 | |
| BioMarin Pharmaceutical (BMRN) | 4.2 | $56M | 598k | 93.07 | |
| Pacira Pharmaceuticals (PCRX) | 3.7 | $49M | 1.3M | 37.55 | |
| Horizon Pharma | 3.3 | $45M | 3.5M | 12.68 | |
| Mirati Therapeutics | 3.2 | $43M | 3.7M | 11.70 | |
| Avexis | 3.2 | $42M | 437k | 96.73 | |
| Dermira | 3.1 | $41M | 1.5M | 27.00 | |
| Zogenix | 2.7 | $36M | 1.0M | 35.05 | |
| Global Blood Therapeutics In | 2.6 | $35M | 1.1M | 31.05 | |
| Iovance Biotherapeutics (IOVA) | 2.4 | $33M | 4.2M | 7.75 | |
| Assembly Biosciences | 2.4 | $32M | 907k | 34.92 | |
| Teligent | 2.3 | $31M | 4.6M | 6.71 | |
| Tesaro | 1.9 | $25M | 195k | 129.10 | |
| Intec Pharma | 1.5 | $20M | 2.2M | 8.95 | |
| Vanda Pharmaceuticals (VNDA) | 1.3 | $18M | 988k | 17.90 | |
| AVEO Pharmaceuticals | 1.3 | $18M | 4.8M | 3.65 | |
| Myokardia | 1.3 | $17M | 398k | 42.85 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.9 | $12M | 4.6M | 2.52 | |
| Agenus (AGEN) | 0.8 | $11M | 2.5M | 4.41 | |
| Argenx Se (ARGX) | 0.7 | $9.7M | 430k | 22.61 | |
| BioCryst Pharmaceuticals (BCRX) | 0.7 | $9.3M | 1.8M | 5.24 | |
| Alimera Sciences | 0.6 | $8.4M | 6.2M | 1.35 | |
| Veracyte (VCYT) | 0.6 | $8.2M | 937k | 8.77 | |
| Dbv Technologies S A (DBVT) | 0.6 | $8.2M | 194k | 42.44 | |
| Cascadian Therapeutics | 0.6 | $7.4M | 1.8M | 4.09 | |
| Viveve Med | 0.4 | $5.4M | 1.0M | 5.24 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.2 | $2.5M | 6.0M | 0.42 | |
| Cellectis S A (CLLS) | 0.2 | $2.2M | 78k | 28.45 | |
| Ovascience | 0.1 | $1.6M | 1.1M | 1.42 | |
| Oncobiologics | 0.1 | $936k | 684k | 1.37 | |
| Fennec Pharmaceuticals (FENC) | 0.1 | $731k | 67k | 10.97 | |
| Spdr S&p 500 Etf (SPY) | 0.0 | $470k | 250k | 1.88 | |
| Oncobiologics Inc *w exp 02/18/201 | 0.0 | $28k | 233k | 0.12 | |
| Oncobiologics Inc *w exp 05/18/201 | 0.0 | $12k | 233k | 0.05 |
